Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Effect of Aromatase Inhibitors on Bones and Genes
Overcoming Endocrine Resistance in Metastatic Breast Cancer
† Study has passed its completion date and status has not been verified in more than two years.